Report
Mike Jeremy

Interim results: resilience and confidence

Overall performance shows resilience to the impact of COVID-19, with comprehensive restructuring and a focus on recurring, software-driven, revenue streams. H1’21 revenue grew 2.3%YoY (normalised basis) to £6.4m. Checkit UK, acquired on 24 May 2019, contributed 2.5 months of earnings, in H1’20 equivalent to £6.2m on an annualised basis. Notably, gross profitability improved significantly from 21.9% at July 2019 to 9% by July 2020. The cash position as of 31 July was £13.4m, compared to £14.3m on 31 January.

With healthy cash resources and cost controls in place Checkit plans to continue a programme of product development and marketing, in which £1.0m was invested in the half year (H1’20: £1.2m). As a result, the company expects to record a near-term operating loss. COVID-19 has brought into focus the services Checkit offers, particularly as working practices change, perhaps permanently. This means management of dispersed workforces through more, data-driven, remote monitoring, an increased reliance on automated, continuous systems surveillance and access to analytical tools for improvement. The factors introduced by COVID-19 effectively define Checkit’s strengths in the provision of SaaS-based, automated monitoring and workflow management services (CAM, CWM and CBM) and analytical tools.

We reinstate forecasts based on estimated 2.3%YoY (normalised) revenue growth this year to £13.1m followed by +7%YoY in FY22 (£14.0m), underpinned by strong recurring revenue growth of 34% and 22% respectively. We expect continued investment in product, sales and marketing, resulting in near-term operating losses of £4.0m in FY21 and £3.0m in FY22 within a programme primed by strong cash reserves which we estimate at £10.1m at year-end FY21 and £7.5m at the close of FY22.
Underlying
Checkit

Elektron Technology is a global business that designs, manufactures and markets products that connect, monitor and control. Co. has three business segments: Bulgin, which products are sealed connectors for the demanding environments, and custom product and system development; Instrumentation, Monitoring and Control, which key products are ophthalmic instruments, nanopositioning and sensing equipment, and materials testing equipment; and Checkit, which key products are cloud-based work management software based on interactive checklists, and smart wireless sensors for continuous automated monitoring.

Provider
Equity Development
Equity Development

​Equity Development enables companies to become better understood and supported by investors. Since our launch in 1996 we have consistently focused on helping our clients improve their communication and relationships with both existing and potential shareholders. Our clients have come from a wide variety of sectors and domiciles, are both private and quoted and range in size from micro-cap to $multi-billions. We offer free access to company research notes written by experienced analysts. These notes include detailed forecasts, financial models and a fair value. We host regular Private Investor Forums at which investors have the opportunity to hear company directors present, and to ask questions. These are free to attend. We broadcast live Webinars with company management that include active Q&A. We also make the recordings available online. We arrange face to face meetings between private investors and company management. We are active users of Twitter, commenting daily on company news, share price moves, Directors’ Dealings, Equity Development Research Notes & Events.

Analysts
Mike Jeremy

Other Reports on these Companies
Other Reports from Equity Development

ResearchPool Subscriptions

Get the most out of your insights

Get in touch